Latest news with #ClinicalImmunology
Globe and Mail
17-07-2025
- Health
- Globe and Mail
EAACI Leadership Reflects on Record-Breaking Congress 2025: A Pivotal Moment for Allergy and Immunology
ZURICH, July 17, 2025 (GLOBE NEWSWIRE) -- With over 7,600 delegates in attendance, EAACI Congress 2025 made headlines not just for its scale but for the powerful message delivered by its leadership. Now, one month after the Congress concluded in Glasgow, EAACI's top figures are sharing their reflections on what they call a turning point for the field. Held from 13–16 June at the Scottish Event Campus, the event championed the theme: 'Breaking Boundaries in Allergy, Asthma, and Clinical Immunology: Integrating Planetary Health for a Sustainable Future.' 'This year's Congress was a turning point,' said Prof. Maria Torres, EAACI President. 'We are entering an era where scientific innovation, equity in care, and environmental health must move forward together.' The programme featured over 250 hours of lectures, workshops, and symposia, covering groundbreaking advances in drug allergy, T2 inflammation, paediatric asthma, and hereditary angioedema. The Presidential Symposium tackled antimicrobial resistance through a One Health lens, while a timely session on climate change and insect allergy drew global attention to ecological impacts on patient care. Far beyond the walls of the SEC, the EAACI Congress 2025 activated the entire city with initiatives that brought science to the streets. The Clinical Village at the Glasgow Science Centre welcomed the public for hands-on allergy education, while the Beat Allergy Walk & Run raised funds for the Glasgow Children's Hospital Charity, reinforcing EAACI's commitment to social impact and community engagement. 'The spirit of collaboration we witnessed in Glasgow was extraordinary,' said Prof. André Moreira, EAACI Vice President Congresses. 'This energy is now translating into real-world initiatives and global partnerships.' The Congress also highlighted EAACI's dedication to mentorship, digital health innovation, and amplifying patient's voices. The countdown for the EAACI Congress 2026 in Istanbul has officially begun, but you won't have to wait until then to dive back into cutting-edge science. From focused meetings to hands-on courses, EAACI has a packed calendar to keep you inspired all year long. Check out what's coming next at About EAACI The European Academy of Allergy and Clinical Immunology (EAACI) is Europe's largest professional association in the field, committed to advancing research and care for those affected by allergic diseases. Contact: communications@ | +41 44 205 55 33
Yahoo
17-07-2025
- Health
- Yahoo
EAACI Leadership Reflects on Record-Breaking Congress 2025: A Pivotal Moment for Allergy and Immunology
Entrance of the EAACI Congress 2025, SEC in Glasgow ZURICH, July 17, 2025 (GLOBE NEWSWIRE) -- With over 7,600 delegates in attendance, EAACI Congress 2025 made headlines not just for its scale but for the powerful message delivered by its leadership. Now, one month after the Congress concluded in Glasgow, EAACI's top figures are sharing their reflections on what they call a turning point for the field. Held from 13–16 June at the Scottish Event Campus, the event championed the theme: 'Breaking Boundaries in Allergy, Asthma, and Clinical Immunology: Integrating Planetary Health for a Sustainable Future.' 'This year's Congress was a turning point,' said Prof. Maria Torres, EAACI President. 'We are entering an era where scientific innovation, equity in care, and environmental health must move forward together.' The programme featured over 250 hours of lectures, workshops, and symposia, covering groundbreaking advances in drug allergy, T2 inflammation, paediatric asthma, and hereditary angioedema. The Presidential Symposium tackled antimicrobial resistance through a One Health lens, while a timely session on climate change and insect allergy drew global attention to ecological impacts on patient care. Far beyond the walls of the SEC, the EAACI Congress 2025 activated the entire city with initiatives that brought science to the streets. The Clinical Village at the Glasgow Science Centre welcomed the public for hands-on allergy education, while the Beat Allergy Walk & Run raised funds for the Glasgow Children's Hospital Charity, reinforcing EAACI's commitment to social impact and community engagement. 'The spirit of collaboration we witnessed in Glasgow was extraordinary,' said Prof. André Moreira, EAACI Vice President Congresses. 'This energy is now translating into real-world initiatives and global partnerships.' The Congress also highlighted EAACI's dedication to mentorship, digital health innovation, and amplifying patient's voices. The countdown for the EAACI Congress 2026 in Istanbul has officially begun, but you won't have to wait until then to dive back into cutting-edge science. From focused meetings to hands-on courses, EAACI has a packed calendar to keep you inspired all year long. Check out what's coming next at About EAACIThe European Academy of Allergy and Clinical Immunology (EAACI) is Europe's largest professional association in the field, committed to advancing research and care for those affected by allergic diseases. Learn more: Contact: communications@ | +41 44 205 55 33 A photo accompanying this announcement is available at in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
14-04-2025
- Health
- Associated Press
Vinmec Recognized As Vietnam's First Allergy & Clinical Immunology Center of Excellence
HANOI, VIETNAM - Media OutReach Newswire - 14 April 2025 - The Center of Allergy and Clinical Immunology under the Vinmec Healthcare System has officially been chosen as a World Allergy Organization (WAO) Center of Excellence (CoE) — making it the first medical facility in Vietnam to receive this prestigious recognition. This milestone marks a significant advancement in the nation's allergy and clinical immunology, aligning Vietnamese healthcare with international standards. Vinmec Times City's Immunology – Allergy Center named WAO Center of Excellence WAO is a preeminent medical institution in the field of allergy and clinical immunology, comprising 115 national and regional member societies across six continents. The WAO COE are distinguished medical facilities recognized for their outstanding achievements in medical practices, education, research, innovation, and international influences. Following a rigorous multi-stage assessment process — including credentials review, scientific evidence review, and examination of on-site operational capability — Vinmec's Allergy and Clinical Immunology Center met WAO's stringent criteria to earn the COE designation. This international recognition not only affirms Vinmec's expertise in the field but also grants the Center prioritized access to international research collaborations, advanced training and clinical trials, and state-of-the-art treatment modalities through WAO and its global network of leading academic partners. Assoc. Prof. Dr. Nguyen Van Dinh, Director of the Clinical Allergy and Immunology Center at Vinmec, commented: 'Being recognized as a WAO Center of Excellence is a landmark achievement for Vietnam's allergy and clinical immunology. This recognition enables our clinicians and researchers to gain a better understanding of advancements in allergic diagnosis and treatment, participate in research collaborations, and have access to advanced therapies of the world. It also gives our health professionals an opportunity to receive training and capacity building by world-renowned experts, thus delivering the most optimized and personalized treatments that ensure the safety of patients'. Prior to the CoE recognition by WAO, Vinmec's Allergy and Clinical Immunology Center had been the first medical facility in Vietnam to receive dual recognitions in specialized allergy care, including: ADCARE (Atopic Dermatitis Centers of Reference and Excellence) and UCARE (Urticaria Centers of Reference and Excellence). Vinmec's Allergy and Clinical Immunology Center is also the first and only healthcare provider in Vietnam licensed by the Ministry of Health to deploy biologic therapies and advanced immunological treatments for severe chronic allergic and immunological disorders — such as bronchial asthma, atopic dermatitis, chronic urticaria, allergic rhinosinusitis with nasal polyps and prurigo nodularis. Vietnam joins the WAO Centers of Excellence global map Vinmec is currently at the forefront of utilizing genetic testing to screen for drug hypersensitivity risks — thereby personalizing the clinical pathway and enhancing patient safety — and applying monoclonal antibody therapies, a cutting-edge and specialized treatment modality typically available only at leading international medical institutions. Additionally, Vinmec has developed comprehensive diagnostic and management protocols for primary immunodeficiency disorders, offering patients early detection, appropriate intervention, and long-term care. Vinmec now stands among other prestigious WAO Centers of Excellence in the region, including the National University of Singapore, Yonsei University College of Medicine (South Korea), University of Tokyo Hospital (Japan), and Shanghai Jiao Tong University School of Medicine (China). The WAO's recognition follows Vinmec's previous establishment of three internationally accredited Centers of Excellence in Cardiology, Oncology, and Orthopedics & Sports Medicine. These achievements reflect Vinmec's strategic commitment to building globally recognized centers of excellence that deliver innovative, world-class healthcare solutions to Vietnamese and international patients alike. Hashtag: #Vinmec The issuer is solely responsible for the content of this announcement.
